Randomized and prospective clinical trial about the therapeutic use of diatrizoic acid (Gastrografin®) in postoperative ileus.

Fundacio Parc Taulí0 个研究点目标入组 62 人开始时间: 2014年11月19日最近更新: 2018年5月21日

适应症

试验速览

暂无简介。

•- Patients older than 18 years old.
•- Postoperative ileus.
•- Patients that have been submitted to abdominal surgery (including digestive, vascular, gynecologic or urologic procedures). Patients operated for colorectal surgery with protective ostomy.
•- Signed informed consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 31
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 31

•- Patients undergoing abdominal surgery that includes intestinal anastomosis without protective ostomy.
•- Pregnancy or lactancy.
•- Mechanical bowel obstruction.
•- Intestinal isquemia
•- Allergy to Gastrografin® (or other radiological contrast) or other situation detailed in the Gastrografin's datasheet that contraindicate its use.
•- Postoperative complications that could cause paralytic ileus by themselves. (intraabdominal abscess, intraabdominal haematoma,...).
•- Patients in whose participation in the clinical trial could cause any damage to their health (based on medical criteria)
•- Severe renal failure
•- Severe cardiac failure

发起方

Fundacio Parc Taulí